Provided by Tiger Trade Technology Pte. Ltd.

Johnson & Johnson

238.33
-0.1600-0.07%
Post-market: 237.70-0.6300-0.26%19:59 EDT
Volume:7.40M
Turnover:1.77B
Market Cap:574.21B
PE:27.60
High:241.60
Open:240.00
Low:238.14
Close:238.49
52wk High:251.71
52wk Low:149.04
Shares:2.41B
Float Shares:2.40B
Volume Ratio:0.93
T/O Rate:0.31%
Dividend:5.20
Dividend Rate:2.18%
EPS(TTM):8.64
EPS(LYR):11.03
ROE:26.42%
ROA:8.42%
PB:7.07
PE(LYR):21.60

Loading ...

J&J’s DePuy Synthes agrees to acquire rights to MinMaxMedical’s Gemtrack RF tracking technology

Reuters
·
May 26

Depuy Synthes: Under Agreement, Will Hold Rights of First Negotiation for Additional Global Markets for Novosis

THOMSON REUTERS
·
May 26

J&J’s DePuy Synthes signs exclusive NOVOSIS distribution deal with CGBIO for US, Canada, Australia

Reuters
·
May 26

Depuy Synthes Announces Agreement to Acquire Miniature Radiofrequency Tracking Technology Across Its Joint Reconstruction Portfolio

THOMSON REUTERS
·
May 26

Here's the defensive stock-market trade that works no matter where bond yields end up

Dow Jones
·
May 26

Zeiss Meditec names Vitrolife CEO Bronwyn Brophy O'Connor as CEO

Reuters
·
May 22

Johnson And Johnson MedTech Moves And Innovation Hub Tie In Shape Outlook

Simply Wall St.
·
May 22

Perrigo Co. PLC Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 22

Stocks Ex-Dividend May 26

Dow Jones
·
May 22

Moberg Pharma names Lars Johansson chairman, adds three new board members

Reuters
·
May 21

Johnson & Johnson partners with Abu Dhabi health regulator on global intelligent OR network

Reuters
·
May 21

Johnson & Johnson Advances Creation of Global Intelligent or Network in Collaboration With Department of Health - Abu Dhabi

THOMSON REUTERS
·
May 21

Johnson & Johnson's New Myasthenia Gravis Treatment Receives NMPA Approval

Deep News
·
May 21

Johnson & Johnson says nipocalimab approved in China

Reuters
·
May 21

Johnson & Johnson: Amlodipine (Nicalimab Injection) Has Been Approved in China

THOMSON REUTERS
·
May 21

Implantica study finds RefluxStop cost-effective for GERD in Italian healthcare system

Reuters
·
May 21

Perrigo Co. PLC Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 21

Nanobiotix reports 85.7% ORR in phase 2 CONVERGE lung cancer safety lead-in data

Reuters
·
May 21

FACTBOX-Pharma sector doubles down on AI amid hopes of slashing costs, timelines

Reuters
·
May 20

CONMED appoints Celine Martin, Jeff Mirviss to board effective July 1, 2026

Reuters
·
May 20